Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.

doi:10.1158/1055-9965.EPI-21-0686

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Dec 2021

Davari Danielle R, Orlow Irene, Kanetsky Peter A, Luo Li, Edmiston Sharon N, Conway Kathleen, Parrish Eloise A, Hao Honglin, Busam Klaus J, Sharma Ajay, Kricker Anne, Cust Anne E, Anton-Culver Hoda, Gruber Stephen B, Gallagher Richard P, Zanetti Roberto, Rosso Stefano, Sacchetto Lidia, Dwyer Terence, Ollila David W, Begg Colin B, Berwick Marianne, Thomas Nancy E

Abstract excerpt

BACKGROUND: Genome-wide association studies have reported that genetic variation at ANRIL (CDKN2B-AS1) is associated with risk of several chronic diseases including coronary artery disease, coronary artery calcification, myocardial infarction, and type 2 diabetes mellitus. ANRIL is located at the CDKN2A/B locus, which encodes multiple melanoma tumor suppressors. We investigated the association of these variants...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p15

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to GTP Phosphohydrolases

Share to Lymphocytes, Tumor-Infiltrating

Share to Melanoma

Share to Melanoma, Cutaneous Malignant

Share to Membrane Proteins

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34607836
DOI: 10.1158/1055-9965.EPI-21-0686
PMCID: PMC8643342

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.PMID 34607836Read ↗

Inherited genetic variants associated with occurrence of multiple primary melanoma.Semantic proximity Read ↗

Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.Semantic proximity Read ↗

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study.Semantic proximity Read ↗

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.Semantic proximity Read ↗

Germline PDCDL1 Gene Variants Are Associated with Increased Primary Melanoma Thickness.Semantic proximity Read ↗

Genotyping and differential expression analysis of inflammasome genes in sporadic malignant melanoma reveal novel contribution of CARD8, IL1B and IL18 in melanoma susceptibility and progression.Semantic proximity Read ↗

Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.Semantic proximity Read ↗

Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.Semantic proximity Read ↗

Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.